Allogene Therapeutics

0 followers


Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation... Read more

Industries

Employees

201-500

Links

Org chart

David Chang
President, CEO & Co-Founder

David Chang

Collapse
Christine Cassiano
Evp, Chief Corporate Affairs & Brand Strategy Officer
Susan Lundeen
Chief People Officer
Tim Moore
EVP & CTO
Zachary J. Roberts
EVP, Research & Development & CMO
Earl Douglas
Senior Vice President And General Counsel
Monique D.
Executive Asst To CMO CSO VP Biometrics VP Clinical Operations VP Global Regulatory Affairs
Eike Zimmermann
Senior Director Product Quality Lead
Wei-Meng Zhao
Head Of CMC Quality, Executive Director
Zachary J Roberts M.D.
Executive Vice President Of Research & Development And Chief Medical Officer
Peng Cui
Associate Director Head Of QC Chemistry Biochemistry Lab And Raw Material Management
Danielle Dishmon
Executive Director, Global Medical Affairs
Elizabeth C.
Scientist
Hsin-Yuan Cheng
Senior Principal Scientist
Jin Yang
Senior Scientist
Lilian Wang
Scientist
Lyubov Efros
Scientist
Marie Anand
Senior Associate Scientist
Mark O'Dair
Principal Scientist
Nga Chan
Associate Scientist
Sindy Mancuso
Senior Associate Scientist
Taylor Karst
Senior Associate Scientist
Upendra Chitgupi
Senior Scientist
Janet Lee
Associate Director
Marissa D'Inca
Vice President, Head Of Financial Planning & Analysis
Debbie W.
Senior A P Accountant
Hien do
Associate Director, Drug Safety Operations And Compliance
Ben Beneski
Vice President, Product Development And Manufacturing
Amy Kinsey
Vice President Clinical Operations
Geoffrey Parker
Executive Vice President And Chief Financial Officer